Development of viral vectors for gene therapy of beta-chain hemoglobinopathies: optimization of a gamma-globin gene expression cassette.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10090929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correct function of the locus control region may require passage through a nonerythroid cellular environment.

  1999cited by this paper
• Full activity from human beta-globin locus control region transgenes requires 5'HS1, distal beta-globin promoter, and 3' beta-globin sequences.

  1998cited by this paper
• Comparison of expression of human globin genes transferred into mouse erythroleukemia cells and in transgenic mice.

  1998cited by this paper
• Sheltering of gamma-globin expression from position effects requires both an upstream locus control region and a regulatory element 3' to the A gamma-globin gene

  1997cited by this paper
• Age-dependent silencing of globin transgenes in the mouse.

  1996cited by this paper
• Production of genetically stable high-titer retroviral vectors that carry a human gamma-globin gene under the control of the alpha-globin locus control region.

  1996cited by this paper
• Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene.

  1995cited by this paper
• Use of yeast artificial chromosomes (YACs) in studies of mammalian development: production of beta-globin locus YAC mice carrying human globin developmental mutants.

  1995cited by this paper
• Mutagenesis of retroviral vectors transducing human beta‐globin gene and beta‐globin locus control region derivatives results in stable transmission of an active transcriptional structure.

  1994cited by this paper
• Position independence and proper developmental control of gamma-globin gene expression require both a 5' locus control region and a downstream sequence element

  1994cited by this paper
• Transcriptional activation of human zeta 2 globin promoter by the alpha globin regulatory element (HS-40): functional role of specific nuclear factor-DNA complexes

  1993cited by this paper
• Developmental regulation of human gamma-globin genes in transgenic mice

  1993cited by this paper
• Analysis of the human alpha globin upstream regulatory element (HS‐40) in transgenic mice.

  1992cited by this paper
• Characterization of the major regulatory element upstream of the human alpha-globin gene cluster

  1991cited by this paper
• Human gamma-globin genes silenced independently of other genes in the beta-globin locus.

  1991cited by this paper
• The mouse Pgk-1 gene promoter contains an upstream activator sequence.

  1991cited by this paper
• Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells.

  1990cited by this paper
• Expression of the human gamma-globin gene after retroviral transfer to transformed erythroid cells.

  1990cited by this paper
• Detailed analysis of the site 3 region of the human beta‐globin dominant control region.

  1990cited by this paper
• The beta‐globin dominant control region: hypersensitive site 2.

  1990cited by this paper
• Definition of the minimal requirements within the human beta‐globin gene and the dominant control region for high level expression.

  1990cited by this paper
• A major positive regulatory region located far upstream of the human alpha-globin gene locus.

  1990cited by this paper
• High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells.

  1990cited by this paper
• Molecular analysis of the human beta-globin locus activation region.

  1989cited by this paper
• Improved retroviral vectors for gene transfer and expression.

  1989cited by this paper
• Beta-globin enhancers target expression of a heterologous gene to erythroid tissues of transgenic mice

  1989cited by this paper
• The human beta‐globin gene contains multiple regulatory regions: identification of one promoter and two downstream enhancers.

  1988cited by this paper
• Expression of the human beta-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells

  1988cited by this paper
• A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell

  1988cited by this paper
• Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Expression of the affected A gamma globin gene associated with Greek nondeletion hereditary persistence of fetal hemoglobin

  1987cited by this paper
• Position-independent, high-level expression of the human beta-globin gene in transgenic mice.

  1987cited by this paper
• The human beta-globin gene contains a downstream developmental specific enhancer.

  1987cited by this paper
• Two 3' sequences direct adult erythroid-specific expression of human beta-globin genes in transgenic mice.

  1987cited by this paper
• An enhancer element lies 3′ to the human A gamma globin gene.

  1987cited by this paper
• Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

  1986cited by this paper
• A developmentally stable chromatin structure in the human beta-globin gene cluster.

  1986cited by this paper
• The "beta-like-globin" gene domain in human erythroid cells.

  1985cited by this paper

• The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34+ Cells from Sickle Cell Disease Patients

  2022cites this paper
• βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells

  2020cites this paper
• Gene therapy for sickle cell disease: An update.

  2018cites this paper
• Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

  2016cites this paper
• Decrease of a-chains in b-thalassemia

  2013cites this paper
• Development of gene therapy for thalassemia.

  2012cites this paper
• Μελέτη της δράσης φορέων τύπου spuma που εκφράζουν anti-α σφαιρίνης shRNA (short hairpin RNA) και β-σφαιρίνη σε πειραματικά μοντέλα θαλασσαιμίας

  2011cites this paper
• Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia

  2011cites this paper
• Cluster specific regulation pattern of upstream regulatory elements in human alpha- and beta-globin gene clusters.

  2008cites this paper
• A novel single step double positive double negative selection strategy for beta-globin gene replacement.

  2006cites this paper
• Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors

  2006cites this paper
• Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin

  2005cites this paper
• Differences of globin transgene expression in stably transfected cell lines and transgenic mice.

  2005cites this paper
• Treatment of β-Thalassemia Patients with Recombinant Human Erythropoietin: Effect on Transfusion Requirements and Soluble Adhesion Molecules

  2004cites this paper
• Evaluation of optimal expression cassette in retrovirus vector for β-thalassemia gene therapy

  2003cites this paper
• Antierythropoietin antibodies in thalassemia patients

  2003cites this paper
• Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo.

  2002cites this paper
• High-Level Erythroid Lineage-Directed Gene Expression Using Globin Gene Regulatory Elements After Lentiviral Vector-Mediated Gene Transfer into Primitive Human and Murine Hematopoietic Cells

  2002cites this paper
• Analysis of adeno-associated virus-mediated ex vivo transferred human beta-globin gene in bone marrow engrafted mice.

  2002cites this paper
• Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides.

  2002cites this paper
• Gene Therapy for Hereditary Hematological Disorders

  2001cites this paper
• Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient

  2001cites this paper
• Advances in experimental treatment of beta-thalassaemia.

  2001cites this paper
• Locus Control Region of the Human CD2Gene in a Lentivirus Vector Confers Position-Independent Transgene Expression

  2001cites this paper
• Gene Transfer into Nonhuman Primate Hematopoietic Stem Cells: Implications for Gene Therapy

  2001cites this paper
• Development of a Stable Retrovirus Vector Capable of Long‐Term Expression of γ‐Globin mRNA in Mouse Erythrocytes

  2001cites this paper
• Locus control region activity by 5′HS3 requires a functional interaction with β-globin gene regulatory elements: expression of novel β/γ-globin hybrid transgenes

  2000cites this paper
• Progress towards hematopoietic stem cell gene therapy.

  2000cites this paper
• Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients.

  2000cites this paper
• Glucocorticoid-Inducible Retrovector for Regulated Transgene Expression in Genetically Engineered Bone Marrow Stromal Cells

  2000cites this paper
• Locus control region activity by 5'HS3 requires a functional interaction with beta-globin gene regulatory elements: expression of novel beta/gamma-globin hybrid transgenes.

  2000cites this paper
• Primary T Lymphocytes as Targets for Gene Therapy

  2000cites this paper
• Globin gene therapy: one (seemingly) small vector change, one giant leap in optimism.

  2000cites this paper
• Comparison of two kinds of methods to determine the titer of recombinant retrovirus containing β-globin gene based on G418 selection

  2000cites this paper
• Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter.

  2000cites this paper
• Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.

  1999cites this paper